De-identified Human Tissue Project
Launched by UNIVERSITY OF CENTRAL FLORIDA · Oct 8, 2023
Trial Information
Current as of November 12, 2025
Recruiting
Keywords
ClinConnect Summary
The De-identified Human Tissue Project is a research study being conducted by scientists at the University of Central Florida. The goal of this study is to understand human diseases better and to find new ways to diagnose and treat various medical conditions. Researchers will be looking at human tissue samples that have been anonymized, meaning the donors' identities are not known. They will focus on several important areas, including cancer, heart health, immune system diseases, brain health, and infections.
This study is currently recruiting participants, and anyone aged 65 to 74 can be eligible, as long as the tissue samples come from approved sources. Participants in this study won't have to do anything extra; their tissue samples will be used in laboratory research to help improve medical knowledge and develop new treatments. It's a great opportunity to contribute to science and potentially help others in the future!
Gender
ALL
Eligibility criteria
- Inclusion:
- • - de-identified human tissue from cooperating institutions for unknown/undisclosed donors.
About University Of Central Florida
The University of Central Florida (UCF) is a leading research institution dedicated to advancing knowledge and improving health outcomes through innovative clinical trials. With a commitment to excellence in research and education, UCF leverages its diverse expertise and state-of-the-art facilities to conduct cutting-edge studies across various medical disciplines. The university's collaborative approach fosters partnerships with healthcare providers, industry leaders, and community organizations, ensuring that clinical trials are designed to address pressing health challenges while adhering to the highest ethical standards. UCF is dedicated to translating research findings into practical applications that enhance patient care and contribute to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Orlando, Florida, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported